drugset / Trial / NCT00562211

Efficacy of a New Topical Anesthetic

NCT00562211 ↗

Phase 1/2 Completed 40 enrolled Rambam Health Care Campus
RandomizedParallel-groupSingle-blindTreatment

Summary

A new topical anesthetic which contains 5% lidocaine and a disinfection ingredient has been developed and is tested in this study (LidoDyn). The study examines the efficacy of LidoDyn by comparing it with an already proven anesthetic agent (EMLA crème).

Timeline

Start
2007-11
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator EMLA creme Unknown 2 g Topical
Subject LidoDyn Unknown 2 g Topical

Indications

No indication recorded.